Arginyl-Glutamine Dipeptide (Infant Bacterial Therapeutics)

N/A

Report date: 2022/11/04 16:15:25
NME

Base Information

Drug NameArginyl-Glutamine Dipeptide (Infant Bacterial Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRetinopathy of Prematurity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesInfant Bacterial Therapeutics Ab
Inactive CompaniesN/A
Active IndicationsRetinopathy of Prematurity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A